A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

Background Cardiovascular disease (CVD) is the leading cause of mortality worldwide, while depression is highly prevalent in this patient population and has long been regarded as an independent risk ...